1)岩瀬愛子:正常眼圧緑内障の疫学:多治見スタディから.あたらしい眼科20:1343-1349, 2003
2)日本眼科学会緑内障診療ガイドライン作成委員会:緑内障診療ガイドライン(第4版), 2018
3)Leske MC, Heijl A, Hussein M et al:Factors for glaucoma progression and the effect of treatment:the early manifest glaucoma trial. Arch Ophthalmol 121:48-56, 2003
4)Collaborative Normal-Tension Glaucoma Study Group:Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 126:487-497, 1998
5)Wilson WS, Duncan AJ, Jay JL:Effect of benzalkonium chloride on the stability of the precorneal tear film in rabbit and man. Br J Ophthalmol 59:667-669, 1975
6)Baudouin C, Labbé A, Liang H et al:Preservatives in eyedrops:the good, the bad and the ugly. Prog Retin Eye Res 29:312-334, 2010
7)添田尚一・井上賢治・富田剛司・他:ラタノプロスト・チモロールマレイン酸塩配合点眼液からトラボプロスト・チモロールマレイン酸塩配合点眼液への切替え.あたらしい眼科30:861-864,2013
8)宮田和典・沢 充・西田輝夫・他:びまん性表層角膜炎の重症度の分類.臨眼48:183-188,1994
9)土坂寿行・金 恵媛・松元 俊・他:多施設におけるtimololおよびcarteololの比較試験.眼臨85:1136-1140,1991
10)藤本隆志・井上賢治・若倉雅登・他:カルテオロール2回点眼から1回点眼への変更による長期効果.あたらしい眼科26:987-990,2009
11)Jaenen N, Baudouin C, Pouliquen P et al:Ocular symptoms and signs with preserved and preservative-free glaucoma medications. Eur J Ophthalmol 17:341-349, 2007
12)Van Buskirk EM:Corneal anesthesia after timolol maleate therapy. Am J Ophthalmol 88:739-743, 1979
13)Chrisp P, Sorkin EM:Ocular carteolol. A review of its pharmacological properties, and therapeutic use in glaucoma and ocular hypertension. Drugs Aging 2:58-77, 1992
14)河合憲司・大橋秀記・鈴木崇弘・他:ヒトおよびマウス末梢血単核球の炎症性サイトカイン産生に及ぼす緑内障治療薬の作用.日眼会誌114:669-677, 2010
15)Séchoy O, Tissié G, Sébastian C, et el:A new long acting ophthalmic formulation of carteolol containing alginic acid. International Journal of Pharmaceutics. 207:109-116, 2000
16)Tokuda N, Inoue J, Yamazaki I:Effects of a long-acting ophthalmic formulation of carteolol containing alginic acid on the corneal epithelial barrier function and water retentive effect. J Ocul Pharmacol Ther 28:123-128, 2012
17)Fuongfuchat A, Jamieson AM, Blackwell J et al:Gerken Rheological studies of the interaction of mucins with alginate and polyacrylate. Carbohydrate Research 284:85-99, 1996
18)Uematsu M, Kumagami T, Shimoda K:Polyoxyethylene hydrogenated castor oil modulates benzalkonium chloride toxicity:comparison of acute corneal barrier dysfunction induced by travoprost Z and travoprost. J Ocul Pharmacol Ther 27:437-444, 2011